Effect of inosiplex (Isoprinosine®) on induced human influenza A infection

A double blind prospective controlled study to evaluate the effect of inosiplex in induced human influenza A infection was carried out. Inosiplex was administered in therapeutic (starting 48 h following challenge) or prophylactic-therapeutic (starting 48 h prior to challenge) manner in a dose of 4 g per day. Although the number of volunteers with clinical illness in the two treatment groups wa…